BioAtla, Inc. (BCAB)

BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $8.55 million. The enterprise value is $8.76 million.

Market Cap	8.55M
Enterprise Value	8.76M

Important Dates

The next estimated earnings date is Tuesday, May 5, 2026, after market close.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 1.66 million shares outstanding. The number of shares has increased by 21.11% in one year.

Current Share Class	1.66M
Shares Outstanding	1.66M
Shares Change (YoY)	+21.11%
Shares Change (QoQ)	+1.79%
Owned by Insiders (%)	7.30%
Owned by Institutions (%)	11.04%
Float	1.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.84
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.37

Current Ratio	0.37
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-110.76%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	725.29%
Weighted Average Cost of Capital (WACC)	6.64%
Revenue Per Employee	$48,780
Profits Per Employee	-$1.45M
Employee Count	41
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.10% in the last 52 weeks. The beta is 1.21, so BioAtla's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-71.10%
50-Day Moving Average	7.53
200-Day Moving Average	23.43
Relative Strength Index (RSI)	39.59
Average Volume (20 Days)	54,226

Short Selling Information

Short Interest	2.37M
Short Previous Month	1.92M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.71

Income Statement

In the last 12 months, BioAtla had revenue of $2.00 million and -$59.61 million in losses. Loss per share was -$50.66.

Revenue	2.00M
Gross Profit	-41.07M
Operating Income	-58.71M
Pretax Income	-59.61M
Net Income	-59.61M
EBITDA	-58.33M
EBIT	-58.71M
Loss Per Share	-$50.66

Balance Sheet

The company has $7.12 million in cash and $6.20 million in debt, with a net cash position of $918,000 or $0.55 per share.

Cash & Cash Equivalents	7.12M
Total Debt	6.20M
Net Cash	918,000
Net Cash Per Share	$0.55
Equity (Book Value)	-36.19M
Book Value Per Share	-28.51
Working Capital	-13.91M

Cash Flow

Operating Cash Flow	-48.20M
Capital Expenditures	n/a
Depreciation & Amortization	373,000
Net Borrowing	7.13M
Free Cash Flow	-48.20M
FCF Per Share	-$29.09

Margins

Gross Margin	n/a
Operating Margin	-2,935.25%
Pretax Margin	-2,980.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.11%
Shareholder Yield	-21.11%
Earnings Yield	-616.00%
FCF Yield	-498.16%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 6, 2026. It was a reverse split with a ratio of 1:50.

Last Split Date	Apr 6, 2026
Split Type	Reverse
Split Ratio	1:50

Scores

BioAtla has an Altman Z-Score of -69.95 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-69.95
Piotroski F-Score	1